
Preclinical testing at The Ohio State University found Telomir-Zn inhibited growth of canine and human osteosarcoma cell lines, prompting the company to explore a possible in-vivo study in dogs with naturally occurring tumors.
Date: January 22 - January 22, 2017
Description:
Event type: Workshop
Event Address:
Sponsor: Oculus Insights
For More Information:Wynnie Zuchowski,Onculus Insights
262-271-7094, [email protected]





